Vaccine maker, FDA talk
81112
PHILADELPHIA -- GlaxoSmithKline is in talks with the Food and Drug Administration about selling its Fluarix influenza vaccine in the United States this season because of the expected flu vaccine shortage this year.
429855
US health authorities seeking desperately to overcome a massive shortage of flu vaccine in that country are in discussions with Canada&#39;s major influenza vaccine producer, the company confirmed today.
126844
The decision by British authorities to suspend the license of a major influenza vaccine manufacturer just before the vaccine was to be shipped shows a need for better communication, acting FDA chief Dr. Lester Crawford said on Monday.
539761
GlaxoSmithKline PLC and Novartis AG, two of the world's biggest vaccine makers, may have bet on the wrong technology in the race to develop a better flu shot.
545492
Is the US Food &amp; Drug Administration failing? That was the testimony of one senior FDA official last week concerning Merck&#39;s withdrawal of the Vioxx anti-pain drug.
106279
US officials say manufacturer Aventis Pasteur can produce another 2.6 million doses of flu vaccine, but the shipment won&#39;t arrive in America until January.
105646
US regulators were trying to decide whether to allow the release of 48 million doses of Chiron Corp.&#39;s flu vaccine when British authorities stepped in to block the company from shipping the vaccine, FDA officials said on
382588
The head of the Food and Drug Administration on Monday strongly defended his agency&#39;s oversight of a flu vaccine factory that was abruptly closed down last week because of safety concerns.
337978
FDA officials on Tuesday are expected to announce whether they will allow four million to five million doses of flu vaccine manufactured in Europe and Canada to be imported for use in the United States, HHS Secretary Tommy Thompson said Friday in his
374799
One of the nation&#39;s two major manufacturers of flu vaccine announced this week that it will delay release of millions of vaccine doses until early October.
567677
Chiron Corp. may begin ramping up for flu vaccine production before British and U.S. regulators have officially re-approved its manufacturing license, under a plan disclosed by Chief Executive Howard Pien on ...
682721
Biotech companies, medical device  makers and food manufacturers joined patient groups and three  former U.S. health secretaries on Monday in calling for  increased funding for the Food and Drug Administration.
307945
GlaxoSmithKline Plc is exploring ways to sell its Fluarix flu vaccine in the United States, where supplies have run short this season after Chiron Corp lost a year&#39;s production to contamination.
454185
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia.
591309
The flu vaccine shortage might stretch into 2005 if one key US supplier cannot resume manufacturing in time. By Henry Barrios, The Bakersfield Californian via AP.
300603
It is unlikely that any of the nearly 50 million doses of influenza vaccine being held at a plant in England will be found safe and released to the United States, the head of the Food and Drug Administration said Friday.
554668
U.S. health officials are talking with several flu vaccine producers worldwide in hopes of securing doses to protect millions left vulnerable when manufacturing problems cost the country half its supply.